Covalon Technologies EBITDA Margin 2013-2024 | CVALF

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Profit Margins Gross Margin Operating Margin EBITDA Margin Pre-Tax Margin Net Margin

Covalon Technologies ebitda margin from 2013 to 2024. Ebitda margin can be defined as earnings before interest, taxes, depreciation and amortization as a portion of total revenue.

Covalon Technologies EBITDA Margin 2013-2024 | CVALF

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Profit Margins Gross Margin Operating Margin EBITDA Margin Pre-Tax Margin Net Margin

Covalon Technologies ebitda margin from 2013 to 2024. Ebitda margin can be defined as earnings before interest, taxes, depreciation and amortization as a portion of total revenue.

Related Stocks
Company Name	Market Cap
Thermo Fisher Scientific (TMO)	$234.6B
Intuitive Surgical (ISRG)	$174.6B
Alcon (ALC)	$48.6B
IQVIA Holdings (IQV)	$43.6B
IDEXX Laboratories (IDXX)	$42.1B
Edwards Lifesciences (EW)	$41.8B
DexCom (DXCM)	$28.1B
STERIS (STE)	$24B
SONOVA HOLDING (SONVY)	$21.5B
Waters (WAT)	$19.5B
Hologic (HOLX)	$19.2B
Sysmex ADR (SSMXY)	$12.3B
Fresenius Medical Care AG KGaA (FMS)	$12.3B
Teleflex (TFX)	$11.6B
Globus Medical (GMED)	$9.5B
Penumbra (PEN)	$7.3B
Glaukos (GKOS)	$6.8B
Masimo (MASI)	$6.1B
TransMedics (TMDX)	$5B
Integer Holdings (ITGR)	$4.3B
PROCEPT BioRobotics (PRCT)	$4.3B
Tandem Diabetes Care (TNDM)	$2.8B
Inari Medical (NARI)	$2.7B
LivaNova (LIVN)	$2.6B
Nihon Kohden (NHNKY)	$2.6B
Veracyte (VCYT)	$2.6B
Elekta AB (EKTAY)	$2.4B
RxSight (RXST)	$2.1B
Integra LifeSciences Holdings (IART)	$1.3B
Pulse Biosciences (PLSE)	$1.2B